367 related articles for article (PubMed ID: 28472613)
21. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
23. A case of clinically aggressive EBV-negative ENKTL in a non-Asian female patient.
Kent T; Scott G; Seifert R
J Hematop; 2023 Mar; 16(1):33-38. PubMed ID: 38175370
[TBL] [Abstract][Full Text] [Related]
24. Extranodal natural-killer/T-cell lymphoma, nasal type: An immunomorphological study from a regional cancer institute in India.
Agrawal M; Champaka G; Amirtham U; Jacob LA; Premalata CS
J Cancer Res Ther; 2022; 18(4):1137-1143. PubMed ID: 36149173
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Tajima S; Takanashi Y; Koda K; Fukayama M
Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype.
Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Shimizu N; Reghunathan R; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
Leuk Lymphoma; 2015; 56(8):2408-15. PubMed ID: 25382618
[TBL] [Abstract][Full Text] [Related]
28. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.
Imai A; Takase H; Imadome KI; Matsuda G; Ohnishi I; Yamamoto K; Kudo T; Tanaka Y; Maehara T; Miura O; Arai A
Intern Med; 2017; 56(11):1409-1414. PubMed ID: 28566607
[TBL] [Abstract][Full Text] [Related]
29. Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
Halabi MA; Jaccard A; Moulinas R; Bahri R; Al Mouhammad H; Mammari N; Feuillard J; Ranger-Rogez S
Int J Cancer; 2016 Aug; 139(4):793-802. PubMed ID: 27061907
[TBL] [Abstract][Full Text] [Related]
30. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
32. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases.
Kato S; Asano N; Miyata-Takata T; Takata K; Elsayed AA; Satou A; Takahashi E; Kinoshita T; Nakamura S
Am J Surg Pathol; 2015 Apr; 39(4):462-71. PubMed ID: 25634749
[TBL] [Abstract][Full Text] [Related]
33. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.
Ng SB; Chung TH; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Yin CC; Soong R; Jeyasekharan AD; Hoppe MM; Selvarajan V; Tan SY; Lim ST; Ong CK; Nairismägi ML; Maheshwari P; Choo SN; Fan S; Lee CK; Chuang SS; Chng WJ
Haematologica; 2018 Feb; 103(2):278-287. PubMed ID: 29097495
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin.
Kim SJ; Kim JH; Ki CS; Ko YH; Kim JS; Kim WS
Ann Oncol; 2016 Mar; 27(3):508-13. PubMed ID: 26658891
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma.
Chen Y; Zheng X; Chen B; Yang X; Zheng J; Zheng Z; Yang T; Liu T; Hu J
Leuk Lymphoma; 2017 Oct; 58(10):2349-2355. PubMed ID: 28306367
[TBL] [Abstract][Full Text] [Related]
37. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
[TBL] [Abstract][Full Text] [Related]
39. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).
Mao Y; Zhang DW; Zhu H; Lin H; Xiong L; Cao Q; Liu Y; Li QD; Xu JR; Xu LF; Chen RJ
Diagn Pathol; 2012 Dec; 7():178. PubMed ID: 23237707
[TBL] [Abstract][Full Text] [Related]
40. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.
Zhang YH; Li Z; Zhao S; Zhang WY; Liu QL; Liu WP; Gao LM
Ann Hematol; 2023 Oct; 102(10):2803-2813. PubMed ID: 37434096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]